Olanzapine

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Olanzapine

Biochem/physiol Actions Olanzapine is a 5-HT2 serotonin and D1/D2 dopamine receptor antagonist. Features and Benefits This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction.

InformationOlanzapine (LY170053) is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.In vitroOlanzapine interacts with key receptors of interest in schizophrenia, having a nanomolar affinity for dopaminergic, serotonergic,

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

OLANZAPINE THIOLACTAM

An antipsychotic, thienobenzodiazepine compound that binds as an antagonist/inverse agonist to dopamine D1 (Ki = 31 nM), dopamine D2 (Ki = 11 nM), dopamine D4 (Ki = 27 nM), serotonin 5-HT2A (Ki = 4 nM), serotonin 5-HT2C (Ki = 11 nM), serotonin 5-HT3

An antipsychotic, thienobenzodiazepine compound that binds as an antagonist/inverse agonist to dopamine D1 (Ki = 31 nM), dopamine D2 (Ki = 11 nM), dopamine D4 (Ki = 27 nM), serotonin 5-HT2A (Ki = 4 nM), serotonin 5-HT2C (Ki = 11 nM), serotonin 5-HT3

An antipsychotic, thienobenzodiazepine compound that binds as an antagonist/inverse agonist to dopamine D1 (Ki = 31 nM), dopamine D2 (Ki = 11 nM), dopamine D4 (Ki = 27 nM), serotonin 5-HT2A (Ki = 4 nM), serotonin 5-HT2C (Ki = 11 nM), serotonin 5-HT3